🔴 MEDPAL AI is trading 5% down; no clear company-specific catalyst

MEDPAL AI is trading 5.39% down at £4.84, but the specific reason for the October 19 decline remains unclear.

• No fresh company-specific announcement explaining the decline was found; its latest update reported customer growth and a higher Mounjaro supplier ranking.
• The broader London market also opened lower on October 19 amid investor concerns about US technology earnings and market pressures.
• Available evidence does not establish that broader weakness directly caused MEDPAL AI’s decline.